Related Experiment Video
Updated: Jun 23, 2026

08:05
Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
Published on: December 12, 2011
Measurement and quality control issues in multiplex protein assays: a case study
Allison A Ellington1, Iftikhar J Kullo, Kent R Bailey
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Clinical Chemistry
|April 18, 2009
Summary
Multiplex immunoassay measurements of 15 protein biomarkers revealed significant challenges in assay optimization and quality control. Further analytical and statistical developments are needed for reliable multiplexed biomarker analysis.
Area of Science:
- Biomarker Discovery
- Assay Development
- Proteomics
Background:
- Multiplex arrays offer efficient protein biomarker measurement, conserving specimens and reducing costs.
- However, challenges exist in assay format optimization, dilution factor selection, and quality control (QC).
- This study examines processing, analytic, and QC issues in multiplexed immunoassays using 15 protein biomarkers.
Purpose of the Study:
- To illustrate processing, analytic, and quality control challenges encountered with multiplexed immunoassays.
- To analyze the impact of protocol deviations and sample handling on measurement accuracy.
- To explore potential alternative quality control algorithms for multiplexed data.
Main Methods:
- Duplicate measurements of 15 proteins were performed on 2322 participants using custom planar microarrays.
- Standardized protocols for sample processing, storage, and freeze-thaw cycles were applied.
- Data were analyzed for effects of processing deviations, precision, and bias, including clustering of duplicate measurements.
Main Results:
- While measurements were within reportable ranges, 7 of 15 proteins lacked centered dose-response curves.
- Additional freeze-thaw cycles and dilution errors significantly altered results.
- Duplicate measurement differences clustered by analyte, plate, and participant, challenging conventional QC algorithms.
Conclusions:
- Multiplexed immunoassay measurements present substantial analytical and statistical challenges.
- Robust quality control algorithms are crucial for reliable data interpretation.
- Further development is needed to overcome these hurdles in biomarker analysis.

